Grantham, Mayo, Van Otterloo & Co (GMO)’s Avantax, Inc. Common Stock AVTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-58,000
Closed -$1.07M 809
2022
Q2
$1.07M Sell
58,000
-27,500
-32% -$500K 0.01% 511
2022
Q1
$1.67M Buy
85,500
+16,500
+24% +$299K 0.01% 467
2021
Q4
$1.2M Buy
+69,000
New +$1.17M 0.01% 523
2019
Q1
Sell
-7,900
Closed -$210K 754
2018
Q4
$210K Hold
7,900
﹤0.01% 507
2018
Q3
$318K Sell
7,900
-7,200
-48% -$262K ﹤0.01% 478
2018
Q2
$559K Sell
15,100
-18,100
-55% -$584K ﹤0.01% 457
2018
Q1
$817K Sell
33,200
-7,700
-19% -$183K 0.01% 394
2017
Q4
$904K Sell
40,900
-22,100
-35% -$493K 0.01% 368
2017
Q3
$1.59M Buy
63,000
+46,800
+289% +$1.06M 0.01% 350
2017
Q2
$343K Buy
+16,200
New +$321K ﹤0.01% 448

Other funds holding AVTA

Grantham, Mayo, Van Otterloo & Co (GMO)'s AVTA Position: Q3 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Avantax, Inc. Common Stock (AVTA) in Q3 2022, closing a stake of 58,000 shares — an estimated $1.07M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AVTA in Q2 2017 and held it in 10 quarters. The position peaked at $1.67M in Q1 2022. 156 funds tracked by Wall St. Rank hold AVTA as of Q3 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Avantax, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 58,000 Avantax, Inc. Common Stock shares in Q3 2022, an estimated $1.07M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Avantax, Inc. Common Stock in Q2 2017 and held it in 10 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Avantax, Inc. Common Stock position peaked at $1.67M in Q1 2022.
  • 156 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q3 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.